SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+9.74%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$554M
AUM Growth
+$554M
(-2.4%)
Cap. Flow
-$70.7M
Cap. Flow
% of AUM
-12.76%
Top 10 Holdings %
Top 10 Hldgs %
48.85%
Holding
147
New
23
Increased
32
Reduced
53
Closed
29
Top Buys
| 1 |
Ormat Technologies
ORA
|
$19.9M |
| 2 |
Pfizer
PFE
|
$19.5M |
| 3 |
Biogen
BIIB
|
$11.9M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$5.76M |
| 5 |
Opko Health
OPK
|
$5.03M |
Top Sells
| 1 |
Elbit Systems
ESLT
|
$29.2M |
| 2 |
SHPG
Shire pic
SHPG
|
$26.6M |
| 3 |
AGN
Allergan plc
AGN
|
$24.1M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$12.7M |
| 5 |
Viatris
VTRS
|
$8.05M |
Sector Composition
| 1 | Healthcare | 74.78% |
| 2 | Utilities | 7.14% |
| 3 | Technology | 2.29% |
| 4 | Consumer Discretionary | 1.7% |
| 5 | Communication Services | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
PTC Therapeutics
PTCT
$3.92B
| $2.14M | 0.31% | 66,020 +62,020 | +1,551% | +$2.01M |
|
|
PTN
77
DELISTED
Palatin Technologies
PTN
| $2.08M | 0.3% | 3,132,926 -225,557 | -7% | -$150K |
|
|
CYNA
78
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $2.07M | 0.3% | 134,037 -54,893 | -29% | -$848K |
|
79
Arbutus Biopharma
ABUS
$711M
| $2.02M | 0.3% | 454,500 -50,500 | -10% | -$225K |
|
80
Abeona Therapeutics
ABEO
$350M
| $2.02M | 0.3% | 600,000 | – | – |
|
81
Axsome Therapeutics
AXSM
$6.05B
| $2.01M | 0.29% | +220,000 | New | +$2.01M |
|
82
PDS Biotechnology
PDSB
$57.8M
| $1.94M | 0.28% | +155,000 | New | +$1.94M |
|
83
SCYNEXIS
SCYX
$34.9M
| $1.89M | 0.28% | 304,600 -8,400 | -3% | -$52.2K |
|
|
TBRA
84
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $1.89M | 0.28% | 187,622 +50,000 | +36% | +$503K |
|
|
PVLA
85
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $1.86M | 0.27% | 810,000 -90,000 | -10% | -$206K |
|
|
ALPN
86
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.79M | 0.26% | 231,548 +29,828 | +15% | +$231K |
|
|
OCRX
87
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $1.72M | 0.25% | 550,000 +50,000 | +10% | +$156K |
|
|
TRIL
88
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.67M | 0.24% | 132,300 -14,700 | -10% | -$185K |
|
|
GWPH
89
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.65M | 0.24% | 23,790 -19,310 | -45% | -$1.34M |
|
90
Aldeyra Therapeutics
ALDX
$351M
| $1.62M | 0.24% | 238,500 -26,500 | -10% | -$180K |
|
|
TSRO
91
DELISTED
TESARO, Inc.
TSRO
| $1.61M | 0.24% | 30,686 -86,814 | -74% | -$4.54M |
|
92
Novartis
NVS
$245B
| $1.55M | 0.23% | 18,000 -2,000 | -10% | -$172K |
|
|
NBRV
93
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $1.5M | 0.22% | 157,500 -17,500 | -10% | -$167K |
|
94
Axalta
AXTA
$6.77B
| $1.5M | 0.22% | 56,173 +15,547 | +38% | +$414K |
|
95
NXP Semiconductors
NXPI
$59.2B
| $1.43M | 0.21% | +16,920 | New | +$1.43M |
|
|
SBBP
96
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.38M | 0.2% | +181,818 | New | +$1.38M |
|
97
KalVista Pharmaceuticals
KALV
$678M
| $1.3M | 0.19% | 360,000 -40,000 | -10% | -$145K |
|
98
ProQR Therapeutics
PRQR
$237M
| $1.3M | 0.19% | +150,000 | New | +$1.3M |
|
|
LOXO
99
DELISTED
Loxo Oncology, Inc
LOXO
| $1.28M | 0.19% | +45,000 | New | +$1.28M |
|
100
Wabtec
WAB
$33.1B
| $908K | 0.13% | 12,761 -9,974 | -44% | -$710K |
|